MAP3K5 and renal fibrosis: In light of the above findings, this study assessed whether LCZ696 treatment would confer protection against renal fibrosis by inhibiting ASK1/JNK/p38 MAPK pathway-mediated apoptotic cell death in a rat model of UUO, and in vitro.